| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 15.07. | Simris Group AB: Simris Group Ab Appoints Adc Expert Professor Andreas Pahl As Chief Executive Officer Of Its Subsidiary Simris Biologics Gmbh | 244 | GlobeNewswire (Europe) | Simris Group AB (SIMRIS B) today announced the appointment of Professor Andreas Pahl as Chief Executive Officer of Simris Biologics GmbH, its wholly owned subsidiary based in Berlin, Germany. Professor... ► Artikel lesen | |
| 24.06. | Simris Group AB: Bulletin from Simris Group AB's annual general meeting | 171 | GlobeNewswire (Europe) | Simris Group AB (publ), reg. no. 556841-9187 (the "Company"), held its annual general meeting on 24 June 2026. Below follows a summary of the resolutions that were passed at the general meeting
Income... ► Artikel lesen | |
| 13.05. | Simris Group AB: Simris Group Interim Report January-march 2026 | 216 | GlobeNewswire (Europe) | QUARTER 1, JANUARY - MARCH 2026Net revenue increased by 167% to SEK 424k (159k).EBITDA improved by 41% to SEK -2 183k (-3 724k).EBIT/Operating result improved by 23% to SEK -5 626k (-7 288k).KEY EVENTS... ► Artikel lesen | |
| 12.05. | Simris Group AB: Simris Group Advances Asset Divestment Process with Two Prospective Buyers | 360 | GlobeNewswire (Europe) | Simris Group AB (Simris or the Company) today announces progress in its strategic divestment process for its microalgae production facility in Hammenhög, Sweden. Simris has entered into a Memorandum... ► Artikel lesen | |
| 11.03. | Simris Group AB: Simis provides an update on the divestment of its assets in Hammenhög, Sweden | 201 | GlobeNewswire (Europe) | Simris Group AB ("Simris" or the "Company") announces that discussions with Immunrise Biocontrol France SAS ("Immunrise") continue, on a non-exclusive basis, beyond the deadline of March 1, 2026 and... ► Artikel lesen | |
| 28.02. | Simris Group AB: Simris Group Year-end Report January-december 2025 | 490 | GlobeNewswire (Europe) | QUARTER 4, JULY - DECEMBER 2025Net revenue decreased by 71% to SEK 285k (971k).EBITDA declined by 63% to SEK -5 196k (-3 180k).EBIT/Operating result improved by 9% to SEK -8 429 (-9 241k).YEAR-END PERIOD... ► Artikel lesen | |
| SIMRIS GROUP Aktie jetzt für 0€ handeln | |||||
| 19.01. | Simris Group AB: Bulletin from Simris Group AB's extraordinary general meeting | 334 | GlobeNewswire (Europe) | Simris Group AB (publ), reg. no. 556841-9187 (the "Company"), held an extraordinary general meeting on 19 January 2026. Below follows a summary of the resolutions that were passed at the general meeting.
Election... ► Artikel lesen | |
| 12.11.25 | Simris Group AB receives observation status | 258 | GlobeNewswire | Today, November 12, 2025, Simris Group AB (the "Company") disclosed its interim report for the third quarter of 2025 with information on the Company's financial situation.
The rules of Nasdaq... ► Artikel lesen | |
| 12.11.25 | Simris Group AB: Simris Group Interim Report January-september 2025 | 286 | GlobeNewswire (Europe) | QUARTER 3, JULY - SEPTEMBER 2025Net revenue decreased by 37% to SEK 484k (766k).EBITDA declined by 22% to SEK -3 639k (-2 971k).EBIT/Operating result declined by 8% to SEK -7 152k (-6 614k).INTERIM... ► Artikel lesen | |
| 10.11.25 | Simris Group AB: Simris Group announces leadership transition - Daniel Kubitza appointed interim CEO | 335 | GlobeNewswire (Europe) | The Board of Directors of Simris Group has appointed Daniel Kubitza as interim CEO, effective immediately.
Daniel Kubitza has over 20 years of experience in corporate financing, commercialization and... ► Artikel lesen | |
| 05.11.25 | Simris Group AB: Simris Group AB Announces Positive Results from Ongoing Antibody-Drug Conjugate (ADC) Study with Nuvisan | 274 | GlobeNewswire (Europe) | Simris Group AB's wholly owned subsidiary, Simris Biologics GmbH, today announced important progress in its ongoing preclinical study with Nuvisan, a leading European contract research and development... ► Artikel lesen | |
| 06.10.25 | Simris Group AB: Update Regarding In-Vitro Evaluation of Novel Advance Microcystin Payloads | 346 | GlobeNewswire (Europe) | Simris Group AB wholly owned subsidiary, Simris Biologics GmbH, today announced short technical delays in a previously announced study contracted with Nuvisan, a leading European contract research and... ► Artikel lesen | |
| 12.09.25 | Simris Group AB: Simris Biologics awarded €200K in non-dilutive funding for R&D programme to further develop microcystin payloads for Antibody Drug Conjugates (ADCs) | 1.034 | GlobeNewswire (Europe) | Simris Group AB, a pioneer in the development of novel, next-generation Antibody Drug Conjugate (ADC) payloads based on Microcystin (MC) toxin variants, announces that funding has been approved for... ► Artikel lesen | |
| 13.08.25 | Simris Group AB: Simris Group Interim Report January-june 2025 | 323 | GlobeNewswire (Europe) | QUARTER 2, APRIL - JUNE 2025Net revenue increased by 8% to SEK 687k (634k).EBITDA improved by 51% to SEK -2 980k (-6 117k).EBIT/Operating result improved by 32% to SEK -6 693k (-9 822k).INTERIM PERIOD... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BEYOND MEAT | 0,540 | +0,35 % | BEYOND MEAT, INC. - 8-K, Current Report | ||
| OATLY GROUP | 7,900 | +0,25 % | Oatly Q2 2026 Earnings Preview | ||
| CONAGRA BRANDS | 13,010 | -0,15 % | Brutal zusammengestrichen: Anleger fassungslos: Dividende um die Hälfte gekürzt! | Um seine Bilanz zu stärken, kürzt der US-Konsumgüterhersteller Conagra Brands seine Dividende um die Hälfte. Trotzdem steigt die Aktie. Zu den Hintergründen. Die Quartalssaison liefert: Positive Überraschungen... ► Artikel lesen | |
| WINGSTOP | 124,00 | +4,77 % | Why Wingstop (WING) is Poised to Beat Earnings Estimates Again | ||
| WH GROUP | 0,914 | +2,72 % | Jefferies Cuts WH GROUP TP to HKD11.66, Reiterates Rating Buy; 2Q OP Seen Down 11.2% YoY | ||
| MHP | 6,950 | +1,46 % | Ukraine-Spain Business Council Holds Inaugural Meeting; Ukrainian Chapter Led by MHP Executive | KYIV, Ukraine, July 16, 2026 /PRNewswire/ -- The inaugural meeting of the Ukraine-Spain Business Council was held in Kyiv. The Ukrainian chapter of the Council is chaired by Mykhailo Bno-Airiian... ► Artikel lesen | |
| JACK IN THE BOX | 13,000 | 0,00 % | Del Taco Named #1 Fast Food Restaurant and #1 Fast Food Fries in USA Today's 2026 10Best Reader's Choice Awards | ||
| ELSE NUTRITION | 0,067 | 0,00 % | XFRA NEW INSTRUMENTS AVAILABLE ON 10.07.2026 | The following instruments on XETRA do have their first trading 10.07.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 10.07.2026
Aktien
1 CA03771W1005 Apollo Global Management... ► Artikel lesen | |
| J&J SNACK FOODS | 66,50 | 0,00 % | Dividendenbekanntmachungen (16.06.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADTRAN NETWORKS SE DE0005103006 - 0,52 EUR ALTAGAS LTD CA0213611001 0,334 CAD 0,2059 EUR ALTAGAS LTD PRF.G CA0213618865 0,376 CAD 0... ► Artikel lesen | |
| BIOGAIA | 10,890 | -0,18 % | BioGaia AB: Interim Report January - June 2026 | SECOND QUARTER 2026
Net sales amounted to SEK 440.9 million (404.7), an increase of SEK 36.2 million, an increase excluding currency effects of 12% (9% including currency effects).
Net sales in the... ► Artikel lesen | |
| MIDERA FOOD PROCESSING | 45,810 | -0,07 % | Midera Food Processing: Oppenheimer stuft Aktie mit "Outperform" ein | ||
| SWEETGREEN | 6,795 | 0,00 % | Anleger verlieren den Appetit: Krankheitsausbruch in den USA reißt Restaurant-Aktien runter | © Foto: Guillermo Arias - APAktien von Cava, Chipotle und Sweetgreen rutschen ab, bei Taco Bell brechen die Besucherzahlen ein. Ein Cyclospora-Ausbruch in den USA wird plötzlich zum Börsenproblem. Ein... ► Artikel lesen | |
| NESTLE | 92,60 | +1,84 % | Nestle investiert 520 Mio Franken in italienisches Tiernahrungswerk | DJ Nestle investiert 520 Mio Franken in italienisches Tiernahrungswerk
Von Adria Calatayud
DOW JONES--Nestle baut seine Produktionskapazität für Tierfutter aus. Wie die Nestle-Sparte Purina... ► Artikel lesen | |
| SADOT GROUP | 22,200 | +1,56 % | Morning Market Movers: Baiya International Group, Globavend, Advanced Biomed, Sadot Group See Big Swings | CANBERA (dpa-AFX) - At 7:25 a.m. ET on Monday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| SENECA FOODS | 163,24 | -0,07 % | Seneca Foods Corp.: Seneca Foods Reports Sales and Earnings for the Quarter and Twelve Months Ended March 31, 2026 | FAIRPORT, N.Y., June 11, 2026 (GLOBE NEWSWIRE) -- Seneca Foods Corporation (NASDAQ: SENEA, SENEB) today announced financial results for the fourth quarter and twelve months ended March 31, 2026. Executive... ► Artikel lesen |